PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Schmidt Sciences awards $1.95M gift to Mount Sinai's Windreich Department of Artificial Intelligence and Human Health to establish The Eric and Wendy Schmidt AI in Human Health Fellowship Program

2024-02-05
(Press-News.org) New York, NY (February 5, 2024) — The Windreich Department of Artificial Intelligence (AI) and Human Health at the Icahn School of Medicine at Mount Sinai announced a transformative $1.95 million gift from Schmidt Sciences to create The Eric and Wendy Schmidt AI in Human Health Fellowship Program. The gift will support an inaugural cohort of five fellows over a three-year fellowship.

By leveraging AI and machine learning to tackle the increasing volume of data in health care, The Eric and Wendy Schmidt AI in Human Health Fellows will play a pivotal role in advancing medical research. The program aims to attract exceptional talent in machine learning and applications in health care, fostering interdisciplinary collaborations and providing a platform for groundbreaking research.

"Artificial intelligence has the ability to transform society, and there is no place where it can be better harnessed or more impactful than at Mount Sinai. And I continue to be inspired by the significant contributions that Schmidt Sciences is making to advance the scientific community,” says Thomas J. Fuchs, Dr.sc., Dean for Artificial Intelligence and Human Health at Icahn Mount Sinai. “This gift aligns with our shared goal of attracting and developing the next generation of AI leaders to make a meaningful impact on scientific research and discovery, ultimately benefiting patients everywhere."

The fellows will serve as instructors at Icahn Mount Sinai, focusing on specific projects while collaborating with Mount Sinai's internationally renowned faculty. The fellows will also benefit from the Department's commitment to creating an "intelligent fabric" that integrates machine learning and AI-driven decision-making throughout the Mount Sinai Health System, facilitating breakthroughs in disease prevention, treatment, and quality of life.

The Eric and Wendy Schmidt AI in Human Health Fellowship Program seeks to accelerate AI research at Mount Sinai by cultivating a consistent influx of talented junior and senior faculty. Strengthened by strategic alliances with institutions such as Rensselaer Polytechnic Institute, Cornell Tech, and other prominent universities, Mount Sinai is poised to enhance its ability to attract top-tier talent.

“AI has tremendous potential to change the process of scientific discovery and revolutionize health care. The Eric and Wendy Schmidt AI in Human Health Fellowship Program aligns with our core mission at Schmidt Sciences to find the ideas, people, and techniques across disciplines of science and technology to catalyze results for society,” says Stu Feldman, Schmidt Sciences President and Chief Scientist. “It is a privilege to work with Mount Sinai on this initiative to enhance the AI knowledge of fresh thinkers and enable them to apply new technical approaches to medical care. I hope this new program can achieve real breakthroughs to benefit patients everywhere.”

-####-    

About Mount Sinai's Windreich Department of AI and Human Health

Mount Sinai's Windreich Department of AI and Human Health, the first such department in a U.S. medical school, is committed to advancing and optimizing artificial intelligence and human health. 

Chaired by Thomas J. Fuchs, Dr.sc., the department is dedicated to harnessing the power of leading-edge tools to revolutionize scientific research and discovery. This commitment is realized through the creation of an "intelligent fabric," seamlessly integrating machine learning and AI-driven decision-making throughout Mount Sinai’s entire health system. It includes the distinguished Icahn School of Medicine at Mount Sinai, serving as a central hub for innovative learning. This integration facilitates robust partnerships spanning all research institutes, academic departments, hospitals, and outpatient centers. Through this strategic approach, the Department is accelerating progress in disease prevention, treating severe illnesses, and enhancing overall quality of life for all.

About the Icahn School of Medicine at Mount Sinai

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to a large and diverse patient population.  

Ranked 13th nationwide in National Institutes of Health (NIH) funding and among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges, Icahn Mount Sinai has a talented, productive, and successful faculty. More than 3,000 full-time scientists, educators, and clinicians work within and across 44 academic departments and 36 multidisciplinary institutes, a structure that facilitates tremendous collaboration and synergy. Our emphasis on translational research and therapeutics is evident in such diverse areas as genomics/big data, virology, neuroscience, cardiology, geriatrics, as well as gastrointestinal and liver diseases. 

Icahn Mount Sinai offers highly competitive MD, PhD, and Master’s degree programs, with current enrollment of approximately 1,300 students. It has the largest graduate medical education program in the country, with more than 2,000 clinical residents and fellows training throughout the Health System. In addition, more than 550 postdoctoral research fellows are in training within the Health System. 

A culture of innovation and discovery permeates every Icahn Mount Sinai program. Mount Sinai’s technology transfer office, one of the largest in the country, partners with faculty and trainees to pursue optimal commercialization of intellectual property to ensure that Mount Sinai discoveries and innovations translate into healthcare products and services that benefit the public.

Icahn Mount Sinai’s commitment to breakthrough science and clinical care is enhanced by academic affiliations that supplement and complement the School’s programs.

Through the Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai. Additionally, MSIP develops research partnerships with industry leaders such as Merck & Co., AstraZeneca, Novo Nordisk, and others.

The Icahn School of Medicine at Mount Sinai is located in New York City on the border between the Upper East Side and East Harlem, and classroom teaching takes place on a campus facing Central Park. Icahn Mount Sinai’s location offers many opportunities to interact with and care for diverse communities. Learning extends well beyond the borders of our physical campus, to the eight hospitals of the Mount Sinai Health System, our academic affiliates, and globally.

------------------------------------------------------- 

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Beth Israel; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.

 

 

 

 

END



ELSE PRESS RELEASES FROM THIS DATE:

NFL PLAY 60 Fitness Break broadcast delivers movement minutes in advance of Super Bowl LVIII

2024-02-05
DALLAS, Feb. 5, 2024 — The American Heart Association and the National Football League (NFL), in collaboration with its 32 NFL clubs, are challenging kids to get moving and PLAY 60 in advance of Super Bowl LVIII with the latest installment of the NFL PLAY 60 Fitness Break broadcast series. On Thursday, February 8 at 1 p.m. ET/ 12 p.m. CT/ 10 a.m. PT the Association and the NFL will deliver an action packed, 15-minute synchronous broadcast to help students add movement to their day leading up to the big game along with ...

Microbial division of labor produces higher biofuel yields

Microbial division of labor produces higher biofuel yields
2024-02-05
CHAMPAIGN, Ill. — Scientists have found a way to boost ethanol production via yeast fermentation, a standard method for converting plant sugars into biofuels. Their approach, detailed in the journal Nature Communications, relies on careful timing and a tight division of labor among synthetic yeast strains to yield more ethanol per unit of plant sugars than previous approaches have achieved. “We constructed an artificial microbial community consisting of two engineered yeast strains: a glucose specialist and a xylose specialist,” said Yong-Su Jin, a professor of food science and human nutrition ...

Fencing young mussels for ecosystem restoration

Fencing young mussels for ecosystem restoration
2024-02-05
The restoration of mussel beds in the Wadden Sea or the Delta is a lot more successful when young mussels are helped a little with low, protective fences on the bottom. That is shown by research conducted by marine biologist Jildou Schotanus at the Hogeschool Zeeland / University of Applied Sciences in Vlissingen and at the Royal Netherlands Institute for Sea Research in Yerseke. She defends her thesis Restoring mussel beds on highly dynamic mudflats at the University of Groningen on Monday February 5th. Ecosystem engineers Mussels are so-called ecosystem ...

Mild Covid-19 infections make insomnia more likely, especially in people with anxiety or depression

2024-02-05
Although most patients diagnosed with Covid-19 will quickly recover, some people experience symptoms that linger well after they start testing negative again — including insomnia. Scientists already knew that insomnia was common in patients who had to be hospitalized, but a team of scientists led by Dr Huong T. X. Hoang of Phenikaa University, Vietnam began to wonder if mild infections might also affect sleep quality. “As a sleep researcher, I received many questions and complaints from relatives, friends, ...

Winners of the 2024 Hill Prizes announced

Winners of the 2024 Hill Prizes announced
2024-02-05
Hill Prize in Medicine Awarded to Martin M. Matzuk, M.D., Ph.D. (NAS), Baylor College of Medicine Hill Prize in Engineering Awarded to Maria A. Croyle, Ph.D., The University of Texas at Austin Hill Prize in Biological Sciences Awarded to Russell A. DeBose-Boyd, Ph.D. (NAS), UT Southwestern Medical Center Hill Prize in Physical Sciences Awarded to Allan H. MacDonald, Ph.D. (NAS), The University of Texas at Austin Hill Prize in Technology Awarded to Hermann Lebit, Ph.D., Alma Energy February 5, 2024 – Austin – TAMEST ...

Beyond the pedals: testing upper limb feasibility of cardiopulmonary exercise testing

Beyond the pedals: testing upper limb feasibility of cardiopulmonary exercise testing
2024-02-05
How can inclusivity be achieved in cardiopulmonary exercise tests for individuals facing lower limb injuries or disabilities that make it impossible to pedal a bicycle? Conventional exercise assessments rely primarily on lower limb exercise to determine maximal oxygen uptake – a cardiopulmonary function metric that indicates the maximum amount of oxygen that can be taken into the body in one minute. If lower limbs cannot be exercised, it necessitates an upper limb alternative. However, no clear upper limb ...

Making drug use less dangerous for users is the only way to tackle overdose epidemic

2024-02-05
With more than 100,000 drug overdose deaths in the United States in one year, communities need more than ‘just say no’ drug prevention education and abstinence-only addiction treatment to save lives, an expert has warned. Statistics show that most people who complete conventional drug prevention education as youth eventually go on to use alcohol, nicotine, or illegal drugs. Harm reduction expert Sheila P. Vakharia, PhD, MSW, explains: “The majority have experimented, others use socially, and some experience substance-related problems or addictions. And, regardless of their patterns of use, most have never been taught strategies for safer substance use, ...

Veterinary drug newly found in illicit opioid supply resistant to naloxone

2024-02-05
An article published in CMAJ (Canadian Medical Association Journal) describes five things clinicians and harm reduction workers should know about xylazine, a veterinary medication adulterating the illicit opioid supplyhttps://www.cmaj.ca/lookup/doi/10.1503/cmaj.231603. There is no antidote to the effects of xylazine, and the authors explain that xylazine contamination should be suspected when naloxone appears not to work effectively in people with opioid toxicity. Highlights: Xylazine is not approved for use in humans and is increasingly found in illicit drug samples along with fentanyl. People using ...

Difficulty swallowing, allergies in children and young adults: is it eosinophilic esophagitis?

2024-02-05
Children and young adults with allergies or eczema who have difficulty swallowing may have eosinophilic esophagitis. A review published in CMAJ (Canadian Medical Association Journal) provides guidance on how to diagnose and manage this chronic inflammatory disease https://www.cmaj.ca/lookup/doi/10.1503/cmaj.230378. In people with eosinophilic esophagitis, the esophageal lining is inflamed, which can cause injury and narrowing of the throat. Although it can affect anyone, the risk is higher in children aged 5–14 years ...

Down to the core of poxviruses

Down to the core of poxviruses
2024-02-05
A recent re-emergence and outbreak of Mpox brought poxviruses back as a public health threat, underlining an important knowledge gap at their core. Now, a team of researchers from the Institute of Science and Technology Austria (ISTA) lifted the mysteries of poxviral core architecture by combining various cryo-electron microscopy techniques with molecular modeling. The findings, published in Nature Structural & Molecular Biology, could facilitate future research on therapeutics targeting the poxvirus core. Variola virus, the most notorious poxvirus and one of the deadliest viruses to have ...

LAST 30 PRESS RELEASES:

Study outlines key role of national and EU policy to control emissions from German hydrogen economy

Beloved Disney classics convey an idealized image of fatherhood

Sensitive ceramics for soft robotics

Trends in hospitalizations and liver transplants associated with alcohol-induced liver disease

Spinal cord stimulation vs medical management for chronic back and leg pain

Engineered receptors help the immune system home in on cancer

How conflicting memories of sex and starvation compete to drive behavior

Scientists discover ‘entirely unanticipated’ role of protein netrin1 in spinal cord development

Novel SOURCE study examining development of early COPD in ages 30 to 55

NRL completes development of robotics capable of servicing satellites, enabling resilience for the U.S. space infrastructure

Clinical trial shows positive results for potential treatment to combat a challenging rare disease

New research shows relationship between heart shape and risk of cardiovascular disease

Increase in crisis coverage, but not the number of crisis news events

New study provides first evidence of African children with severe malaria experiencing partial resistance to world’s most powerful malaria drug

Texting abbreviations makes senders seem insincere, study finds

Living microbes discovered in Earth’s driest desert

Artemisinin partial resistance in Ugandan children with complicated malaria

When is a hole not a hole? Researchers investigate the mystery of 'latent pores'

ETRI, demonstration of 8-photon qubit chip for quantum computation

Remote telemedicine tool found highly accurate in diagnosing melanoma

New roles in infectious process for molecule that inhibits flu

Transforming anion exchange membranes in water electrolysis for green hydrogen production

AI method can spot potential disease faster, better than humans

A development by Graz University of Technology makes concreting more reliable, safer and more economical

Pinpointing hydrogen isotopes in titanium hydride nanofilms

Political abuse on X is a global, widespread, and cross-partisan phenomenon, suggests new study

Reintroduction of resistant frogs facilitates landscape-scale recovery in the presence of a lethal fungal disease

Scientists compile library for evaluating exoplanet water

Updated first aid guidelines enhance care for opioid overdose, bleeding, other emergencies

Revolutionizing biology education: Scientists film ‘giant’ mimivirus in action

[Press-News.org] Schmidt Sciences awards $1.95M gift to Mount Sinai's Windreich Department of Artificial Intelligence and Human Health to establish The Eric and Wendy Schmidt AI in Human Health Fellowship Program